Immuno-oncology Clinical Trials and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Immuno-oncology Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-oncology Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-oncology Clinical Trials Overall Market Size
2.1 Global Immuno-oncology Clinical Trials Market Size: 2021 VS 2028
2.2 Global Immuno-oncology Clinical Trials Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-oncology Clinical Trials Players in Global Market
3.2 Top Global Immuno-oncology Clinical Trials Companies Ranked by Revenue
3.3 Global Immuno-oncology Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 Immuno-oncology Clinical Trials Companies in Global Market, by Revenue in 2021
3.5 Global Companies Immuno-oncology Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-oncology Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 Immuno-oncology Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 Immuno-oncology Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Immuno-oncology Clinical Trials Market Size Markets, 2021 & 2028
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - Global Immuno-oncology Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global Immuno-oncology Clinical Trials Revenue, 2017-2022
4.2.2 By Type - Global Immuno-oncology Clinical Trials Revenue, 2023-2028
4.2.3 By Type - Global Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-oncology Clinical Trials Market Size, 2021 & 2028
5.1.2 Solid Tumors
5.1.3 Hematological Cancer
5.2 By Application - Global Immuno-oncology Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global Immuno-oncology Clinical Trials Revenue, 2017-2022
5.2.2 By Application - Global Immuno-oncology Clinical Trials Revenue, 2023-2028
5.2.3 By Application - Global Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Immuno-oncology Clinical Trials Market Size, 2021 & 2028
6.2 By Region - Global Immuno-oncology Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global Immuno-oncology Clinical Trials Revenue, 2017-2022
6.2.2 By Region - Global Immuno-oncology Clinical Trials Revenue, 2023-2028
6.2.3 By Region - Global Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Immuno-oncology Clinical Trials Revenue, 2017-2028
6.3.2 US Immuno-oncology Clinical Trials Market Size, 2017-2028
6.3.3 Canada Immuno-oncology Clinical Trials Market Size, 2017-2028
6.3.4 Mexico Immuno-oncology Clinical Trials Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Immuno-oncology Clinical Trials Revenue, 2017-2028
6.4.2 Germany Immuno-oncology Clinical Trials Market Size, 2017-2028
6.4.3 France Immuno-oncology Clinical Trials Market Size, 2017-2028
6.4.4 U.K. Immuno-oncology Clinical Trials Market Size, 2017-2028
6.4.5 Italy Immuno-oncology Clinical Trials Market Size, 2017-2028
6.4.6 Russia Immuno-oncology Clinical Trials Market Size, 2017-2028
6.4.7 Nordic Countries Immuno-oncology Clinical Trials Market Size, 2017-2028
6.4.8 Benelux Immuno-oncology Clinical Trials Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Immuno-oncology Clinical Trials Revenue, 2017-2028
6.5.2 China Immuno-oncology Clinical Trials Market Size, 2017-2028
6.5.3 Japan Immuno-oncology Clinical Trials Market Size, 2017-2028
6.5.4 South Korea Immuno-oncology Clinical Trials Market Size, 2017-2028
6.5.5 Southeast Asia Immuno-oncology Clinical Trials Market Size, 2017-2028
6.5.6 India Immuno-oncology Clinical Trials Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Immuno-oncology Clinical Trials Revenue, 2017-2028
6.6.2 Brazil Immuno-oncology Clinical Trials Market Size, 2017-2028
6.6.3 Argentina Immuno-oncology Clinical Trials Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immuno-oncology Clinical Trials Revenue, 2017-2028
6.7.2 Turkey Immuno-oncology Clinical Trials Market Size, 2017-2028
6.7.3 Israel Immuno-oncology Clinical Trials Market Size, 2017-2028
6.7.4 Saudi Arabia Immuno-oncology Clinical Trials Market Size, 2017-2028
6.7.5 UAE Immuno-oncology Clinical Trials Market Size, 2017-2028
7 Players Profiles
7.1 Medpace
7.1.1 Medpace Corporate Summary
7.1.2 Medpace Business Overview
7.1.3 Medpace Immuno-oncology Clinical Trials Major Product Offerings
7.1.4 Medpace Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.1.5 Medpace Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Immuno-oncology Clinical Trials Major Product Offerings
7.2.4 Novartis Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Exscientia
7.3.1 Exscientia Corporate Summary
7.3.2 Exscientia Business Overview
7.3.3 Exscientia Immuno-oncology Clinical Trials Major Product Offerings
7.3.4 Exscientia Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.3.5 Exscientia Key News
7.4 Syneous Health
7.4.1 Syneous Health Corporate Summary
7.4.2 Syneous Health Business Overview
7.4.3 Syneous Health Immuno-oncology Clinical Trials Major Product Offerings
7.4.4 Syneous Health Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.4.5 Syneous Health Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Immuno-oncology Clinical Trials Major Product Offerings
7.5.4 AstraZeneca Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.5.5 AstraZeneca Key News
7.6 ICON plc
7.6.1 ICON plc Corporate Summary
7.6.2 ICON plc Business Overview
7.6.3 ICON plc Immuno-oncology Clinical Trials Major Product Offerings
7.6.4 ICON plc Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.6.5 ICON plc Key News
7.7 IQVIA Holdings
7.7.1 IQVIA Holdings Corporate Summary
7.7.2 IQVIA Holdings Business Overview
7.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Major Product Offerings
7.7.4 IQVIA Holdings Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.7.5 IQVIA Holdings Key News
7.8 BioNtech
7.8.1 BioNtech Corporate Summary
7.8.2 BioNtech Business Overview
7.8.3 BioNtech Immuno-oncology Clinical Trials Major Product Offerings
7.8.4 BioNtech Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.8.5 BioNtech Key News
7.9 Covance, Inc.
7.9.1 Covance, Inc. Corporate Summary
7.9.2 Covance, Inc. Business Overview
7.9.3 Covance, Inc. Immuno-oncology Clinical Trials Major Product Offerings
7.9.4 Covance, Inc. Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.9.5 Covance, Inc. Key News
7.10 IO BIOTECH
7.10.1 IO BIOTECH Corporate Summary
7.10.2 IO BIOTECH Business Overview
7.10.3 IO BIOTECH Immuno-oncology Clinical Trials Major Product Offerings
7.10.4 IO BIOTECH Immuno-oncology Clinical Trials Revenue in Global Market (2017-2022)
7.10.5 IO BIOTECH Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Immuno-oncology Clinical Trials Market Opportunities & Trends in Global Market
Table 2. Immuno-oncology Clinical Trials Market Drivers in Global Market
Table 3. Immuno-oncology Clinical Trials Market Restraints in Global Market
Table 4. Key Players of Immuno-oncology Clinical Trials in Global Market
Table 5. Top Immuno-oncology Clinical Trials Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Immuno-oncology Clinical Trials Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Immuno-oncology Clinical Trials Revenue Share by Companies, 2017-2022
Table 8. Global Companies Immuno-oncology Clinical Trials Product Type
Table 9. List of Global Tier 1 Immuno-oncology Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-oncology Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Immuno-oncology Clinical Trials Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Immuno-oncology Clinical Trials Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Immuno-oncology Clinical Trials Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Immuno-oncology Clinical Trials Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Immuno-oncology Clinical Trials Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Immuno-oncology Clinical Trials Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2023-2028
Table 30. Medpace Corporate Summary
Table 31. Medpace Immuno-oncology Clinical Trials Product Offerings
Table 32. Medpace Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Immuno-oncology Clinical Trials Product Offerings
Table 35. Novartis Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 36. Exscientia Corporate Summary
Table 37. Exscientia Immuno-oncology Clinical Trials Product Offerings
Table 38. Exscientia Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 39. Syneous Health Corporate Summary
Table 40. Syneous Health Immuno-oncology Clinical Trials Product Offerings
Table 41. Syneous Health Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Immuno-oncology Clinical Trials Product Offerings
Table 44. AstraZeneca Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 45. ICON plc Corporate Summary
Table 46. ICON plc Immuno-oncology Clinical Trials Product Offerings
Table 47. ICON plc Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 48. IQVIA Holdings Corporate Summary
Table 49. IQVIA Holdings Immuno-oncology Clinical Trials Product Offerings
Table 50. IQVIA Holdings Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 51. BioNtech Corporate Summary
Table 52. BioNtech Immuno-oncology Clinical Trials Product Offerings
Table 53. BioNtech Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 54. Covance, Inc. Corporate Summary
Table 55. Covance, Inc. Immuno-oncology Clinical Trials Product Offerings
Table 56. Covance, Inc. Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
Table 57. IO BIOTECH Corporate Summary
Table 58. IO BIOTECH Immuno-oncology Clinical Trials Product Offerings
Table 59. IO BIOTECH Immuno-oncology Clinical Trials Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Immuno-oncology Clinical Trials Segment by Type in 2021
Figure 2. Immuno-oncology Clinical Trials Segment by Application in 2021
Figure 3. Global Immuno-oncology Clinical Trials Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immuno-oncology Clinical Trials Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immuno-oncology Clinical Trials Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-oncology Clinical Trials Revenue in 2021
Figure 8. By Type - Global Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 9. By Application - Global Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 10. By Region - Global Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 11. By Country - North America Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 12. US Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 16. Germany Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 17. France Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 24. China Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 28. India Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 30. Brazil Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Immuno-oncology Clinical Trials Revenue Market Share, 2017-2028
Figure 33. Turkey Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Immuno-oncology Clinical Trials Revenue, (US$, Mn), 2017-2028
Figure 37. Medpace Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Exscientia Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Syneous Health Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ICON plc Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. IQVIA Holdings Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BioNtech Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Covance, Inc. Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. IO BIOTECH Immuno-oncology Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
